These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

657 related articles for article (PubMed ID: 34688179)

  • 21. Perilesional neurodegenerative injury in multiple sclerosis: Relation to focal lesions and impact on disability.
    Clarke MA; Lakhani DA; Wen S; Gao S; Smith SA; Dortch R; Xu J; Bagnato F
    Mult Scler Relat Disord; 2021 Apr; 49():102738. PubMed ID: 33609957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postmortem quantitative MRI disentangles histological lesion types in multiple sclerosis.
    Galbusera R; Bahn E; Weigel M; Schaedelin S; Franz J; Lu PJ; Barakovic M; Melie-Garcia L; Dechent P; Lutti A; Sati P; Reich DS; Nair G; Brück W; Kappos L; Stadelmann C; Granziera C
    Brain Pathol; 2023 Nov; 33(6):e13136. PubMed ID: 36480267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective Inversion Recovery Quantitative Magnetization Transfer Brain MRI at 7T: Clinical and Postmortem Validation in Multiple Sclerosis.
    Bagnato F; Hametner S; Franco G; Pawate S; Sriram S; Lassmann H; Gore J; Smith SE; Dortch R
    J Neuroimaging; 2018 Jul; 28(4):380-388. PubMed ID: 29676026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-component relaxation in clinically isolated syndrome: Lesion myelination may predict multiple sclerosis conversion.
    Kitzler HH; Wahl H; Eisele JC; Kuhn M; Schmitz-Peiffer H; Kern S; Rutt BK; Deoni SCL; Ziemssen T; Linn J
    Neuroimage Clin; 2018; 20():61-70. PubMed ID: 30094157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fast whole-brain three-dimensional macromolecular proton fraction mapping in multiple sclerosis.
    Yarnykh VL; Bowen JD; Samsonov A; Repovic P; Mayadev A; Qian P; Gangadharan B; Keogh BP; Maravilla KR; Jung Henson LK
    Radiology; 2015 Jan; 274(1):210-20. PubMed ID: 25208343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myelin water imaging in relapsing multiple sclerosis treated with ocrelizumab and interferon beta-1a.
    Kolind S; Abel S; Taylor C; Tam R; Laule C; Li DKB; Garren H; Gaetano L; Bernasconi C; Clayton D; Vavasour I; Traboulsee A
    Neuroimage Clin; 2022; 35():103109. PubMed ID: 35878575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantifying Remyelination Using χ-Separation in White Matter and Cortical Multiple Sclerosis Lesions.
    Müller J; Lu PJ; Cagol A; Ruberte E; Shin HG; Ocampo-Pineda M; Chen X; Tsagkas C; Barakovic M; Galbusera R; Weigel M; Schaedelin SA; Wang Y; Nguyen TD; Spincemaille P; Kappos L; Kuhle J; Lee J; Granziera C
    Neurology; 2024 Sep; 103(6):e209604. PubMed ID: 39213476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T2 Relaxometry Evidence of Microstructural Changes in Diffusely Abnormal White Matter in Relapsing-Remitting Multiple Sclerosis and Clinically Isolated Syndrome: Impact on Visuomotor Performance.
    Papadaki E; Mastorodemos V; Panou T; Pouli S; Spyridaki E; Kavroulakis E; Kalaitzakis G; Maris TG; Simos P
    J Magn Reson Imaging; 2021 Oct; 54(4):1077-1087. PubMed ID: 33960066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the cortical myeloarchitecture with inhomogeneous magnetization transfer imaging (ihMT).
    Munsch F; Varma G; Taso M; Girard O; Guidon A; Duhamel G; Alsop DC
    Neuroimage; 2021 Jan; 225():117442. PubMed ID: 33039620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter.
    Narayanan S; Francis SJ; Sled JG; Santos AC; Antel S; Levesque I; Brass S; Lapierre Y; Sappey-Marinier D; Pike GB; Arnold DL
    Neuroimage; 2006 Jan; 29(2):637-42. PubMed ID: 16126413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of white matter lesions in multiple sclerosis using proton density and T1-relaxation measures.
    Buch S; Subramanian K; Chen T; Chen Y; Larvie M; Bernitsas E; Haacke EM
    Magn Reson Imaging; 2024 Feb; 106():110-118. PubMed ID: 38145698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myelin content changes in probable Alzheimer's disease and mild cognitive impairment: Associations with age and severity of neuropsychiatric impairment.
    Kavroulakis E; Simos PG; Kalaitzakis G; Maris TG; Karageorgou D; Zaganas I; Panagiotakis S; Basta M; Vgontzas A; Papadaki E
    J Magn Reson Imaging; 2018 May; 47(5):1359-1372. PubMed ID: 28861929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue damage within normal appearing white matter in early multiple sclerosis: assessment by the ratio of T1- and T2-weighted MR image intensity.
    Beer A; Biberacher V; Schmidt P; Righart R; Buck D; Berthele A; Kirschke J; Zimmer C; Hemmer B; Mühlau M
    J Neurol; 2016 Aug; 263(8):1495-502. PubMed ID: 27178000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myelin Water Atlas: A Template for Myelin Distribution in the Brain.
    Liu H; Rubino C; Dvorak AV; Jarrett M; Ljungberg E; Vavasour IM; Lee LE; Kolind SH; MacMillan EL; Traboulsee A; Lang DJ; Rauscher A; Li DKB; MacKay AL; Boyd LA; Kramer JLK; Laule C
    J Neuroimaging; 2019 Nov; 29(6):699-706. PubMed ID: 31347238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age independently affects myelin integrity as detected by magnetization transfer magnetic resonance imaging in multiple sclerosis.
    Newbould RD; Nicholas R; Thomas CL; Quest R; Lee JS; Honeyfield L; Colasanti A; Malik O; Mattoscio M; Matthews PM; Sormani MP; Waldman AD; Muraro PA
    Neuroimage Clin; 2014; 4():641-8. PubMed ID: 24936415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring the Contribution of Myelin Content in Normal Appearing White Matter to Cognitive Outcomes in Cerebral Small Vessel Disease.
    Dao E; Tam R; Hsiung GR; Ten Brinke L; Crockett R; Barha CK; Yoo Y; Al Keridy W; Doherty SH; Laule C; MacKay AL; Liu-Ambrose T
    J Alzheimers Dis; 2021; 80(1):91-101. PubMed ID: 33523006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis.
    Granberg T; Fan Q; Treaba CA; Ouellette R; Herranz E; Mangeat G; Louapre C; Cohen-Adad J; Klawiter EC; Sloane JA; Mainero C
    Brain; 2017 Nov; 140(11):2912-2926. PubMed ID: 29053798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myelin water imaging reflects clinical variability in multiple sclerosis.
    Kolind S; Matthews L; Johansen-Berg H; Leite MI; Williams SC; Deoni S; Palace J
    Neuroimage; 2012 Mar; 60(1):263-70. PubMed ID: 22155325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pilot study comparing myelin measurements from myelin water imaging and
    Vavasour IM; Vafai N; Beauchemin P; Kanjilal C; Badalan A; Shahinfard E; Laule C; Li DK; Traboulsee A; Sossi V; Kolind SH; Carruthers RL
    Mult Scler Relat Disord; 2022 Dec; 68():104238. PubMed ID: 36274287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multi-parametric quantitative MRI of normal appearing white matter in multiple sclerosis, and the effect of disease activity on T2.
    Reitz SC; Hof SM; Fleischer V; Brodski A; Gröger A; Gracien RM; Droby A; Steinmetz H; Ziemann U; Zipp F; Deichmann R; Klein JC
    Brain Imaging Behav; 2017 Jun; 11(3):744-753. PubMed ID: 27138529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.